PlainPharmaWatch

CMS Open Payments · Program Year 2024

International Life Sciences

International Life Sciences reported $883,786.29 in payments to 535 physicians and teaching hospitals across 535 transactions.

See the rankings → How this is sourced
$883.8K
Total payments
535
Transactions
535
Recipients
−$355.0K
General Payments vs PY2023

International Life Sciences reported $883,786.29 in payments to 535 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #647 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.7K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

International Life Sciences pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#647
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

International Life Sciences's CMS-reported General Payments decreased by $355.0K (−28.7%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: INTERNATIONAL LIFE SCIENCESPY2023: INTERNATIONAL LIFE SCIENCESPY2024: International Life Sciences. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.2MPY2024$883.8K
PY2023
$1,238,783.35
PY2024
$883,786.29

How International Life Sciences ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

International Life Sciences's total vs. every reporting company

CMS Open Payments, Program Year 2024

$883,786 Top 34% higher than 66% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for International Life Sciences

$883,786.29: that is what International Life Sciences reported in payments to 535 physicians and teaching hospitals during Program Year 2024, spread across 535 transactions ($1.7K per transaction, $1.7K per recipient). The company sits at rank #647 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $433.5K, accounting for 49.1% of the company's reported total and 18 transactions.

General Payment Breakdown by Type

International Life Sciences made 4 types of general payments. "Royalty or License" is the largest category at $433.5K, 49.1% of the company's reported total.

How International Life Sciences divides its payments

General-payment categories, ordered by reported total

1. Royalty or License$433.5K2. Consulting Fee$381.9K3. Travel and Lodging$47.9K4. Food and Beverage$20.5K
Payment Type Amount Transactions
Royalty or License $433.5K 18
Consulting Fee $381.9K 120
Travel and Lodging $47.9K 177
Food and Beverage $20.5K 220

Recipient Concentration in General Payments

The five largest recipient relationships account for $333,686.26 (37.8%) of $883,786.29 in this company's General Payments records across 272 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for International Life Sciences

The five named recipients with the highest reported General Payments from this company

Jesse Doty$80.6KRyan Scott$69.9KSteven Neufeld$65.9KJohn Ellington$59.6KRobert Anderson$57.7K
  1. 1

    Jesse Doty

    $80,562.53 across 24 reported transactions

  2. 2

    Ryan Scott

    $69,915.42 across 16 reported transactions

  3. 3

    Steven Neufeld

    $65,925.06 across 12 reported transactions

  4. 4

    John Ellington

    $59,570.42 across 7 reported transactions

  5. 5

    Robert Anderson

    $57,712.83 across 7 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.7K. Average per recipient: $1.7K.

Total Amount

$883,786.29

Avg per Transaction

$1.7K

Avg per Recipient

$1.7K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

International Life Sciences Share

0.0%

#647 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to International Life Sciences

Jenavalve Technology, Inc.

$869.0K 185 recipients

Life Technologies Corporation

$868.1K 479 recipients

Sanara MedTech Inc.

$866.5K 2,677 recipients

Motiva USA, LLC

$901.6K 1,217 recipients

L&k Biomed Co. , Ltd.

$864.8K 38 recipients

Canary Medical USA LLC

$903.4K 38 recipients

Frequently Asked Questions

How much did International Life Sciences pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $883,786.29 from International Life Sciences to physicians and hospitals across 535 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from International Life Sciences? ▾
Averaging $1.7K per recipient, International Life Sciences's 2024 payments reached 535 physicians and teaching hospitals.
What types of payments did International Life Sciences make? ▾
International Life Sciences made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Royalty or License" at $433.5K, representing 49.1% of the company's reported total.
How does International Life Sciences rank among pharmaceutical companies? ▾
By total payment amount, International Life Sciences sits at #647 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from International Life Sciences? ▾
In 2024, International Life Sciences averaged $1.7K per transaction across 535 transactions to 535 recipients.
Where does the payment data for International Life Sciences come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download International Life Sciences's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.